nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—IFNG—acquired immunodeficiency syndrome	0.31	0.705	CbGaD
Glucosamine—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	0.227	1	CrCrCtD
Glucosamine—TNF—acquired immunodeficiency syndrome	0.13	0.295	CbGaD
Glucosamine—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0285	0.128	CbGbCtD
Glucosamine—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0277	0.125	CbGbCtD
Glucosamine—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.026	0.117	CbGbCtD
Glucosamine—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0236	0.106	CbGbCtD
Glucosamine—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0236	0.106	CbGbCtD
Glucosamine—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0203	0.0915	CbGbCtD
Glucosamine—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0197	0.0888	CbGbCtD
Glucosamine—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0178	0.0803	CbGbCtD
Glucosamine—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0178	0.0803	CbGbCtD
Glucosamine—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0171	0.077	CbGbCtD
Glucosamine—IFNG—endothelium—acquired immunodeficiency syndrome	0.00328	0.0729	CbGeAlD
Glucosamine—IFNG—blood plasma—acquired immunodeficiency syndrome	0.00291	0.0648	CbGeAlD
Glucosamine—MMP9—endothelium—acquired immunodeficiency syndrome	0.00211	0.0468	CbGeAlD
Glucosamine—MMP9—blood plasma—acquired immunodeficiency syndrome	0.00187	0.0416	CbGeAlD
Glucosamine—NFKB2—lymphoid tissue—acquired immunodeficiency syndrome	0.00167	0.0372	CbGeAlD
Glucosamine—NFKB2—digestive system—acquired immunodeficiency syndrome	0.00165	0.0367	CbGeAlD
Glucosamine—TNF—blood—acquired immunodeficiency syndrome	0.0016	0.0355	CbGeAlD
Glucosamine—NFKB2—blood—acquired immunodeficiency syndrome	0.00157	0.035	CbGeAlD
Glucosamine—TNF—vagina—acquired immunodeficiency syndrome	0.00148	0.0329	CbGeAlD
Glucosamine—IFNG—skin of body—acquired immunodeficiency syndrome	0.0014	0.0311	CbGeAlD
Glucosamine—NFKB2—lung—acquired immunodeficiency syndrome	0.00138	0.0307	CbGeAlD
Glucosamine—IFNG—lymphoid tissue—acquired immunodeficiency syndrome	0.00113	0.0252	CbGeAlD
Glucosamine—IFNG—digestive system—acquired immunodeficiency syndrome	0.00112	0.0249	CbGeAlD
Glucosamine—IFNG—blood—acquired immunodeficiency syndrome	0.00107	0.0237	CbGeAlD
Glucosamine—IFNG—bone marrow—acquired immunodeficiency syndrome	0.00103	0.023	CbGeAlD
Glucosamine—IFNG—spinal cord—acquired immunodeficiency syndrome	0.00103	0.0229	CbGeAlD
Glucosamine—IFNG—vagina—acquired immunodeficiency syndrome	0.00099	0.022	CbGeAlD
Glucosamine—NFKB2—brain—acquired immunodeficiency syndrome	0.000977	0.0217	CbGeAlD
Glucosamine—TNF—lymph node—acquired immunodeficiency syndrome	0.000958	0.0213	CbGeAlD
Glucosamine—NFKB2—lymph node—acquired immunodeficiency syndrome	0.000944	0.021	CbGeAlD
Glucosamine—IFNG—lung—acquired immunodeficiency syndrome	0.000936	0.0208	CbGeAlD
Glucosamine—MMP9—skin of body—acquired immunodeficiency syndrome	0.0009	0.02	CbGeAlD
Glucosamine—IFNG—nervous system—acquired immunodeficiency syndrome	0.000867	0.0193	CbGeAlD
Glucosamine—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000839	0.0186	CbGeAlD
Glucosamine—IFNG—central nervous system—acquired immunodeficiency syndrome	0.000834	0.0185	CbGeAlD
Glucosamine—MMP9—lymphoid tissue—acquired immunodeficiency syndrome	0.000728	0.0162	CbGeAlD
Glucosamine—MMP9—digestive system—acquired immunodeficiency syndrome	0.00072	0.016	CbGeAlD
Glucosamine—MMP9—blood—acquired immunodeficiency syndrome	0.000685	0.0152	CbGeAlD
Glucosamine—MMP9—bone marrow—acquired immunodeficiency syndrome	0.000663	0.0147	CbGeAlD
Glucosamine—IFNG—brain—acquired immunodeficiency syndrome	0.000662	0.0147	CbGeAlD
Glucosamine—MMP9—spinal cord—acquired immunodeficiency syndrome	0.00066	0.0147	CbGeAlD
Glucosamine—IFNG—lymph node—acquired immunodeficiency syndrome	0.00064	0.0142	CbGeAlD
Glucosamine—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000616	0.0137	CbGeAlD
Glucosamine—MMP9—lung—acquired immunodeficiency syndrome	0.000601	0.0134	CbGeAlD
Glucosamine—MMP9—nervous system—acquired immunodeficiency syndrome	0.000556	0.0124	CbGeAlD
Glucosamine—MMP9—central nervous system—acquired immunodeficiency syndrome	0.000536	0.0119	CbGeAlD
Glucosamine—MMP9—brain—acquired immunodeficiency syndrome	0.000425	0.00945	CbGeAlD
Glucosamine—MMP9—lymph node—acquired immunodeficiency syndrome	0.000411	0.00913	CbGeAlD
Glucosamine—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000323	0.00717	CbGeAlD
Glucosamine—CYP2C19—blood—acquired immunodeficiency syndrome	0.000307	0.00683	CbGeAlD
Glucosamine—IFNG—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	0.000298	0.0045	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—IFNA1—acquired immunodeficiency syndrome	0.000296	0.00447	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—IL4—acquired immunodeficiency syndrome	0.00029	0.00438	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—CSF2—acquired immunodeficiency syndrome	0.000286	0.00432	CbGpPWpGaD
Glucosamine—IFNG—IL23-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.000286	0.00432	CbGpPWpGaD
Glucosamine—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000285	0.00633	CbGeAlD
Glucosamine—MMP9—CXCR4-mediated signaling events—CXCR4—acquired immunodeficiency syndrome	0.000284	0.00429	CbGpPWpGaD
Glucosamine—MMP9—CXCR4-mediated signaling events—CXCL12—acquired immunodeficiency syndrome	0.000284	0.00429	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	0.000284	0.00428	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—CSF2—acquired immunodeficiency syndrome	0.000283	0.00428	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—IL4—acquired immunodeficiency syndrome	0.000282	0.00425	CbGpPWpGaD
Glucosamine—IFNG—IL27-mediated signaling events—TNF—acquired immunodeficiency syndrome	0.000276	0.00417	CbGpPWpGaD
Glucosamine—NFKB2—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.000274	0.00414	CbGpPWpGaD
Glucosamine—IFNG—Vitamin B12 Metabolism—ALB—acquired immunodeficiency syndrome	0.000273	0.00412	CbGpPWpGaD
Glucosamine—NFKB2—IL12-mediated signaling events—IFNG—acquired immunodeficiency syndrome	0.00027	0.00407	CbGpPWpGaD
Glucosamine—IFNG—Cytokines and Inflammatory Response—TNF—acquired immunodeficiency syndrome	0.000268	0.00405	CbGpPWpGaD
Glucosamine—NFKB2—IL12-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.000261	0.00393	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—CCL4—acquired immunodeficiency syndrome	0.000256	0.00387	CbGpPWpGaD
Glucosamine—NFKB2—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.00025	0.00377	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—IL10—acquired immunodeficiency syndrome	0.000249	0.00376	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—CSF2—acquired immunodeficiency syndrome	0.000246	0.00372	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—IL4—acquired immunodeficiency syndrome	0.000242	0.00366	CbGpPWpGaD
Glucosamine—IFNG—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.00024	0.00363	CbGpPWpGaD
Glucosamine—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.00024	0.00533	CbGeAlD
Glucosamine—NFKB2—IL12-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.00024	0.00362	CbGpPWpGaD
Glucosamine—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000237	0.00527	CbGeAlD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—CCL5—acquired immunodeficiency syndrome	0.000235	0.00355	CbGpPWpGaD
Glucosamine—NFKB2—TWEAK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000232	0.00351	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.00023	0.00348	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.00023	0.00347	CbGpPWpGaD
Glucosamine—CYP2E1—blood—acquired immunodeficiency syndrome	0.000226	0.00502	CbGeAlD
Glucosamine—IFNG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	0.000225	0.00339	CbGpPWpGaD
Glucosamine—IFNG—IL27-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.000223	0.00336	CbGpPWpGaD
Glucosamine—NFKB2—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.000222	0.00335	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.000222	0.00335	CbGpPWpGaD
Glucosamine—NFKB2—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000218	0.00329	CbGpPWpGaD
Glucosamine—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000218	0.00483	CbGeAlD
Glucosamine—IFNG—Cytokines and Inflammatory Response—IL6—acquired immunodeficiency syndrome	0.000216	0.00326	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000214	0.00322	CbGpPWpGaD
Glucosamine—IFNG—IL2-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.000211	0.00319	CbGpPWpGaD
Glucosamine—IFNG—IL12-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.000211	0.00319	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.00021	0.00318	CbGpPWpGaD
Glucosamine—IFNG—IL23-mediated signaling events—TNF—acquired immunodeficiency syndrome	0.000208	0.00314	CbGpPWpGaD
Glucosamine—IFNG—Interferon Signaling—IFNA1—acquired immunodeficiency syndrome	0.000205	0.0031	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—IFNA1—acquired immunodeficiency syndrome	0.000202	0.00305	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—CCL4—acquired immunodeficiency syndrome	0.0002	0.00302	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—IL2—acquired immunodeficiency syndrome	0.0002	0.00301	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—acquired immunodeficiency syndrome	0.0002	0.00301	CbGpPWpGaD
Glucosamine—NFKB2—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	0.000199	0.003	CbGpPWpGaD
Glucosamine—NFKB2—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000199	0.003	CbGpPWpGaD
Glucosamine—TNF—IL27-mediated signaling events—IFNG—acquired immunodeficiency syndrome	0.000198	0.00299	CbGpPWpGaD
Glucosamine—CYP2E1—lung—acquired immunodeficiency syndrome	0.000198	0.0044	CbGeAlD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—acquired immunodeficiency syndrome	0.000197	0.00298	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.000197	0.00298	CbGpPWpGaD
Glucosamine—IFNG—IL12-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.000194	0.00293	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—acquired immunodeficiency syndrome	0.000194	0.00293	CbGpPWpGaD
Glucosamine—TNF—Cytokines and Inflammatory Response—IFNG—acquired immunodeficiency syndrome	0.000192	0.0029	CbGpPWpGaD
Glucosamine—NFKB2—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000187	0.00283	CbGpPWpGaD
Glucosamine—MMP9—Matrix Metalloproteinases—TNF—acquired immunodeficiency syndrome	0.000187	0.00282	CbGpPWpGaD
Glucosamine—TNF—Cytokines and Inflammatory Response—CD4—acquired immunodeficiency syndrome	0.000186	0.0028	CbGpPWpGaD
Glucosamine—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000183	0.00407	CbGeAlD
Glucosamine—TNF—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	0.000183	0.00276	CbGpPWpGaD
Glucosamine—IFNG—Downstream signaling in naïve CD8+ T cells—IL2—acquired immunodeficiency syndrome	0.00018	0.00272	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.00018	0.00272	CbGpPWpGaD
Glucosamine—MMP9—amb2 Integrin signaling—TNF—acquired immunodeficiency syndrome	0.000177	0.00268	CbGpPWpGaD
Glucosamine—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000177	0.00392	CbGeAlD
Glucosamine—IFNG—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000176	0.00266	CbGpPWpGaD
Glucosamine—TNF—IL27-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.000176	0.00266	CbGpPWpGaD
Glucosamine—IFNG—Regulation of Telomerase—IL2—acquired immunodeficiency syndrome	0.000176	0.00265	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—CCL3—acquired immunodeficiency syndrome	0.000175	0.00264	CbGpPWpGaD
Glucosamine—IFNG—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	0.000175	0.00264	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—IL2—acquired immunodeficiency syndrome	0.000172	0.00259	CbGpPWpGaD
Glucosamine—NFKB2—TSLP Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000171	0.00259	CbGpPWpGaD
Glucosamine—TNF—Cytokines and Inflammatory Response—IL2—acquired immunodeficiency syndrome	0.000171	0.00258	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IFNA1—acquired immunodeficiency syndrome	0.000169	0.00255	CbGpPWpGaD
Glucosamine—IFNG—IL23-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.000168	0.00254	CbGpPWpGaD
Glucosamine—IFNG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	0.000164	0.00247	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000163	0.00247	CbGpPWpGaD
Glucosamine—NFKB2—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.000162	0.00244	CbGpPWpGaD
Glucosamine—IFNG—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	0.000161	0.00243	CbGpPWpGaD
Glucosamine—NFKB2—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	0.00016	0.00242	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.000159	0.00241	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.000159	0.0024	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—CD8A—acquired immunodeficiency syndrome	0.000158	0.00239	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—MBL2—acquired immunodeficiency syndrome	0.000158	0.00238	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—IL2—acquired immunodeficiency syndrome	0.000156	0.00235	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.000155	0.00235	CbGpPWpGaD
Glucosamine—IFNG—Interferon Signaling—HLA-B—acquired immunodeficiency syndrome	0.000154	0.00233	CbGpPWpGaD
Glucosamine—IFNG—TGF-beta Receptor Signaling—TNF—acquired immunodeficiency syndrome	0.000154	0.00232	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—IL2—acquired immunodeficiency syndrome	0.000151	0.00228	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—IL2—acquired immunodeficiency syndrome	0.00015	0.00226	CbGpPWpGaD
Glucosamine—TNF—IL23-mediated signaling events—IFNG—acquired immunodeficiency syndrome	0.000149	0.00225	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—IFNG—acquired immunodeficiency syndrome	0.000146	0.00221	CbGpPWpGaD
Glucosamine—TNF—IL23-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.000144	0.00218	CbGpPWpGaD
Glucosamine—MMP9—amb2 Integrin signaling—IL6—acquired immunodeficiency syndrome	0.000143	0.00216	CbGpPWpGaD
Glucosamine—MMP9—TWEAK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000143	0.00215	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—IFNA1—acquired immunodeficiency syndrome	0.000143	0.00215	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.000141	0.00213	CbGpPWpGaD
Glucosamine—CYP2E1—brain—acquired immunodeficiency syndrome	0.00014	0.00311	CbGeAlD
Glucosamine—TNF—Allograft Rejection—IL10—acquired immunodeficiency syndrome	0.000138	0.00209	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	0.000138	0.00209	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IFNA1—acquired immunodeficiency syndrome	0.000137	0.00207	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—CCL3—acquired immunodeficiency syndrome	0.000137	0.00206	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—IL4—acquired immunodeficiency syndrome	0.000135	0.00203	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000134	0.00203	CbGpPWpGaD
Glucosamine—TNF—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	0.000133	0.00201	CbGpPWpGaD
Glucosamine—TNF—IL23-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.000133	0.002	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—CSF2—acquired immunodeficiency syndrome	0.000132	0.002	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	0.000132	0.00199	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.000131	0.00198	CbGpPWpGaD
Glucosamine—IFNG—Downstream signaling in naïve CD8+ T cells—TNF—acquired immunodeficiency syndrome	0.000131	0.00198	CbGpPWpGaD
Glucosamine—NFKB2—Folate Metabolism—IL6—acquired immunodeficiency syndrome	0.000131	0.00197	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—IL2—acquired immunodeficiency syndrome	0.00013	0.00196	CbGpPWpGaD
Glucosamine—IFNG—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	0.00013	0.00196	CbGpPWpGaD
Glucosamine—NFKB2—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000129	0.00194	CbGpPWpGaD
Glucosamine—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—acquired immunodeficiency syndrome	0.000127	0.00192	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—HLA-B—acquired immunodeficiency syndrome	0.000127	0.00192	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—ALB—acquired immunodeficiency syndrome	0.000127	0.00191	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000125	0.00189	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000124	0.00187	CbGpPWpGaD
Glucosamine—MMP9—CXCR4-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.000122	0.00185	CbGpPWpGaD
Glucosamine—TNF—Transcription factor regulation in adipogenesis—IL6—acquired immunodeficiency syndrome	0.000118	0.00178	CbGpPWpGaD
Glucosamine—NFKB2—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—acquired immunodeficiency syndrome	0.000118	0.00178	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—acquired immunodeficiency syndrome	0.000117	0.00177	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—IL6—acquired immunodeficiency syndrome	0.000117	0.00177	CbGpPWpGaD
Glucosamine—IFNG—ATF-2 transcription factor network—IL6—acquired immunodeficiency syndrome	0.000116	0.00175	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.000115	0.00174	CbGpPWpGaD
Glucosamine—MMP9—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000115	0.00174	CbGpPWpGaD
Glucosamine—NFKB2—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000114	0.00172	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000114	0.00172	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—TNF—acquired immunodeficiency syndrome	0.000114	0.00171	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.000113	0.00171	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	0.000113	0.00171	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.000111	0.00168	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IFNA1—acquired immunodeficiency syndrome	0.000111	0.00168	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—IFNG—acquired immunodeficiency syndrome	0.00011	0.00167	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—CSF2—acquired immunodeficiency syndrome	0.000107	0.00162	CbGpPWpGaD
Glucosamine—NFKB2—MyD88 cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	0.000107	0.00161	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—IL6—acquired immunodeficiency syndrome	0.000106	0.0016	CbGpPWpGaD
Glucosamine—NFKB2—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—acquired immunodeficiency syndrome	0.000106	0.00159	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000105	0.00159	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	0.000104	0.00157	CbGpPWpGaD
Glucosamine—IFNG—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000104	0.00157	CbGpPWpGaD
Glucosamine—NFKB2—MyD88 dependent cascade initiated on endosome—IL6—acquired immunodeficiency syndrome	0.000104	0.00157	CbGpPWpGaD
Glucosamine—NFKB2—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.000104	0.00157	CbGpPWpGaD
Glucosamine—TNF—IL27-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.000103	0.00156	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—HLA-B—acquired immunodeficiency syndrome	0.000103	0.00156	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.000103	0.00155	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—IL6—acquired immunodeficiency syndrome	0.000101	0.00152	CbGpPWpGaD
Glucosamine—TNF—Cytokines and Inflammatory Response—IL6—acquired immunodeficiency syndrome	0.0001	0.00151	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.0001	0.00151	CbGpPWpGaD
Glucosamine—NFKB2—Toll Like Receptor 9 (TLR9) Cascade—IL6—acquired immunodeficiency syndrome	0.0001	0.00151	CbGpPWpGaD
Glucosamine—NFKB2—MyD88:Mal cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	9.84e-05	0.00149	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	9.77e-05	0.00147	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	9.64e-05	0.00146	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ACTG1—acquired immunodeficiency syndrome	9.51e-05	0.00144	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	9.48e-05	0.00143	CbGpPWpGaD
Glucosamine—NFKB2—MyD88-independent cascade—IL6—acquired immunodeficiency syndrome	9.44e-05	0.00143	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	9.4e-05	0.00142	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—IFNG—acquired immunodeficiency syndrome	9.4e-05	0.00142	CbGpPWpGaD
Glucosamine—NFKB2—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	9.22e-05	0.00139	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	8.91e-05	0.00135	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—IL6—acquired immunodeficiency syndrome	8.89e-05	0.00134	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—CCL5—acquired immunodeficiency syndrome	8.84e-05	0.00133	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—IL6—acquired immunodeficiency syndrome	8.8e-05	0.00133	CbGpPWpGaD
Glucosamine—TNF—amb2 Integrin signaling—IL6—acquired immunodeficiency syndrome	8.76e-05	0.00132	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	8.57e-05	0.00129	CbGpPWpGaD
Glucosamine—NFKB2—Activated TLR4 signalling—IL6—acquired immunodeficiency syndrome	8.49e-05	0.00128	CbGpPWpGaD
Glucosamine—IFNG—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	8.4e-05	0.00127	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IL2—acquired immunodeficiency syndrome	8.35e-05	0.00126	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—IL2—acquired immunodeficiency syndrome	8.35e-05	0.00126	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	8.23e-05	0.00124	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	8.18e-05	0.00124	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	8.14e-05	0.00123	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	8.13e-05	0.00123	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	8.03e-05	0.00121	CbGpPWpGaD
Glucosamine—NFKB2—Toll Like Receptor 4 (TLR4) Cascade—IL6—acquired immunodeficiency syndrome	7.99e-05	0.00121	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IFNG—acquired immunodeficiency syndrome	7.87e-05	0.00119	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—MBL2—acquired immunodeficiency syndrome	7.82e-05	0.00118	CbGpPWpGaD
Glucosamine—TNF—IL23-mediated signaling events—IL6—acquired immunodeficiency syndrome	7.8e-05	0.00118	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ACTG1—acquired immunodeficiency syndrome	7.71e-05	0.00116	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—IL6—acquired immunodeficiency syndrome	7.65e-05	0.00115	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	7.46e-05	0.00113	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—IL6—acquired immunodeficiency syndrome	7.3e-05	0.0011	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—IL2—acquired immunodeficiency syndrome	7.23e-05	0.00109	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	7.19e-05	0.00109	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	7.19e-05	0.00109	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	7.13e-05	0.00108	CbGpPWpGaD
Glucosamine—NFKB2—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	7.11e-05	0.00107	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	7.05e-05	0.00106	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	6.99e-05	0.00106	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	6.95e-05	0.00105	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	6.64e-05	0.001	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	6.56e-05	0.00099	CbGpPWpGaD
Glucosamine—IFNG—Immune System—MBL2—acquired immunodeficiency syndrome	6.34e-05	0.000957	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	6.24e-05	0.000942	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CCR2—acquired immunodeficiency syndrome	6.13e-05	0.000926	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	6.03e-05	0.000911	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	5.9e-05	0.000891	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	5.66e-05	0.000855	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IFNA1—acquired immunodeficiency syndrome	5.52e-05	0.000834	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD79A—acquired immunodeficiency syndrome	5.36e-05	0.000809	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	5.25e-05	0.000792	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	5.04e-05	0.00076	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CCR2—acquired immunodeficiency syndrome	4.97e-05	0.00075	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IL6—acquired immunodeficiency syndrome	4.91e-05	0.000741	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IFNA1—acquired immunodeficiency syndrome	4.47e-05	0.000675	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD40LG—acquired immunodeficiency syndrome	4.37e-05	0.00066	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	4.37e-05	0.000659	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.36e-05	0.000658	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.36e-05	0.000658	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD79A—acquired immunodeficiency syndrome	4.34e-05	0.000656	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD8A—acquired immunodeficiency syndrome	4.32e-05	0.000652	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CSF2—acquired immunodeficiency syndrome	4.32e-05	0.000652	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CD4—acquired immunodeficiency syndrome	4.26e-05	0.000643	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HLA-B—acquired immunodeficiency syndrome	4.16e-05	0.000627	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	4.11e-05	0.00062	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.02e-05	0.000608	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.94e-05	0.000595	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	3.9e-05	0.000589	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	3.76e-05	0.000568	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD40LG—acquired immunodeficiency syndrome	3.54e-05	0.000534	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD8A—acquired immunodeficiency syndrome	3.5e-05	0.000528	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CSF2—acquired immunodeficiency syndrome	3.5e-05	0.000528	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	3.46e-05	0.000523	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-B—acquired immunodeficiency syndrome	3.37e-05	0.000508	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	3.33e-05	0.000503	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	3.08e-05	0.000466	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—IL6—acquired immunodeficiency syndrome	2.85e-05	0.000431	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—TAT—acquired immunodeficiency syndrome	2.73e-05	0.000413	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	2.7e-05	0.000408	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.69e-05	0.000406	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IFNG—acquired immunodeficiency syndrome	2.57e-05	0.000388	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD4—acquired immunodeficiency syndrome	2.48e-05	0.000375	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	2.47e-05	0.000372	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.43e-05	0.000368	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.32e-05	0.000351	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—IL6—acquired immunodeficiency syndrome	2.3e-05	0.000348	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.29e-05	0.000346	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.29e-05	0.000346	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL2—acquired immunodeficiency syndrome	2.28e-05	0.000345	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—IL6—acquired immunodeficiency syndrome	2.24e-05	0.000339	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—TAT—acquired immunodeficiency syndrome	2.11e-05	0.000318	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD4—acquired immunodeficiency syndrome	2.01e-05	0.000304	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TNF—acquired immunodeficiency syndrome	1.98e-05	0.0003	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL2—acquired immunodeficiency syndrome	1.85e-05	0.000279	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	1.79e-05	0.000271	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.74e-05	0.000263	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.71e-05	0.000259	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.6e-05	0.000242	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.57e-05	0.000237	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL6—acquired immunodeficiency syndrome	1.34e-05	0.000203	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL6—acquired immunodeficiency syndrome	1.09e-05	0.000164	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—IL6—acquired immunodeficiency syndrome	9.81e-06	0.000148	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.06e-06	0.000137	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.25e-06	0.000125	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.33e-06	8.04e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	4.76e-06	7.19e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	3.68e-06	5.55e-05	CbGpPWpGaD
